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Introduction: Group B streptococcus (GBS), also known as S. agalactiae, is a beta-hemolytic 
opportunistic pathogen that is part of the normal flora in the gastrointestinal tract. Like many 
other streptococcal pathogens, it requires iron from the host for growth and to establish 
virulence.  Several heme binding and acquisition proteins have been identified that have 
provided significant insight into the heme metabolism in other streptococcus spp. A previous 
microarray analysis Group A streptococcus (GAS) showed up-regulation of specific genes in the 
presence of iron.  Further bioinformatic analysis suggested a homologue in GBS.  In addition, 
sequence analysis showed that the gene of interest lies near an iron uptake system.  In the present 
study, we aim to successfully clone the gene in an inducible vector system for recombinant 
protein expression.  In the future, this recombinant protein will be evaluated for its iron and heme 
binding abilities. 
 
Methods: The gene for the putative heme-binding protein (orfX) was cloned from the GBS 
chromosome and inserted into an inducible pET101 plasmid vector, and transformed into Top 10 
competent E. coli cells. The plasmids were extracted by mini-prep to be transformed into BL21 
star E. coli for expression and purification.  
 
Results: So far, gene specific primers have been designed that supported amplification of GBS 
DNA encoding the heme-binding protein by PCR.  An agarose gel showed a concentration of 75 
ng/µL of the purified PCR product.  The PCR product was cloned into the pET101 vector and 
transformed into Top 10 chemically competent cells.  The transformation was confirmed by PCR 
colony screening for the recombinant construct pDJD-01.  The plasmid was extracted from a 
successful transformant with a 30 ng/µL concentration.  
 
Conclusion: Cloning of the GBS open reading frame has led to the creation of a successful 
recombinant construct (pDJD-01).  The newly constructed plasmid will be transformed into E. 
coli and expressed for biochemical and molecular analyses, to evaluate the heme binding 
capabilities of the protein. 
